{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T21:32:36Z","timestamp":1782768756540,"version":"3.54.5"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.bbr.2013.01.039","type":"journal-article","created":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T12:36:29Z","timestamp":1360067789000},"page":"107-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"special_numbering":"C","title":["Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-\u03b2 (A\u03b21\u201340) administration in mice"],"prefix":"10.1016","volume":"244","author":[{"given":"Vanessa V.","family":"dos Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan\u00fabia B.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilliard","family":"Lach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana L\u00facia S.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thereza C.M.","family":"De Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui Daniel","family":"Prediger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2013.01.039_bib0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/306584a0","article-title":"Neuropeptide Y distribution in human brain","volume":"306","author":"Adrian","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2013.01.039_bib0010","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/0024-3205(84)90032-8","article-title":"Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus","volume":"35","author":"Stanley","year":"1984","journal-title":"Life Sciences"},{"key":"10.1016\/j.bbr.2013.01.039_bib0015","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0006-8993(87)91297-2","article-title":"Modulation of memory processing by neuropeptide Y","volume":"421","author":"Flood","year":"1987","journal-title":"Brain Research"},{"key":"10.1016\/j.bbr.2013.01.039_bib0020","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0006-8993(94)90391-3","article-title":"Effects of neuropeptide Y on short-term memory","volume":"653","author":"Cleary","year":"1994","journal-title":"Brain Research"},{"key":"10.1016\/j.bbr.2013.01.039_bib0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0006-8993(99)02119-8","article-title":"Multiple receptors for neuropeptide Y in the hippocampus: putative roles in seizures and cognition","volume":"848","author":"Redrobe","year":"1999","journal-title":"Brain Research"},{"key":"10.1016\/j.bbr.2013.01.039_bib0030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0166-2236(94)90046-9","article-title":"Effects of neuropeptide Y on the electrical properties of neurons","volume":"17","author":"Colmers","year":"1994","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.bbr.2013.01.039_bib0035","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0006-8993(96)00730-5","article-title":"Neuropeptide Y inhibits hippocampal seizures and wet dog shakes","volume":"737","author":"Woldbye","year":"1996","journal-title":"Brain Research"},{"key":"10.1016\/j.bbr.2013.01.039_bib0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0166-2236(98)01284-3","article-title":"Neuropeptide Y: emerging evidence for a functional role in seizure modulation","volume":"22","author":"Vezzani","year":"1999","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.bbr.2013.01.039_bib0045","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0014-2999(88)90182-3","article-title":"Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain","volume":"147","author":"Heilig","year":"1988","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.bbr.2013.01.039_bib0050","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/S0024-3205(02)02159-8","article-title":"Neuropeptide Y (NPY) and depression: from animal studies to the human condition","volume":"71","author":"Redrobe","year":"2002","journal-title":"Life Sciences"},{"key":"10.1016\/j.bbr.2013.01.039_bib0055","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0028-3908(00)00009-5","article-title":"Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram","volume":"39","author":"Husum","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2013.01.039_bib0060","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.biopsych.2009.03.025","article-title":"Positive correlation between the density of neuropeptide y positive neurons in the amygdala and parameters of self-reported anxiety and depression in mesiotemporal lobe epilepsy patients","volume":"66","author":"Frisch","year":"2009","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.bbr.2013.01.039_bib0065","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/157488906778773689","article-title":"Neuropeptide Y as an endogenous antiepileptic, neuroprotective and pro-neurogenic peptide","volume":"1","author":"Xapelli","year":"2006","journal-title":"Recent Patents on CNS Drug Discovery"},{"key":"10.1016\/j.bbr.2013.01.039_bib0070","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1046\/j.1460-9568.1999.00553.x","article-title":"Regional distribution of Y-receptor subtype mRNAs in rat brain","volume":"11","author":"Parker","year":"1999","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.039_bib0075","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0169-328X(97)00017-X","article-title":"Distribution of the neuropeptide Y Y2 receptor mRNA in rat central nervous system","volume":"46","author":"Gustafson","year":"1997","journal-title":"Brain Research Molecular Brain Research"},{"key":"10.1016\/j.bbr.2013.01.039_bib0080","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0169-328X(02)00555-7","article-title":"Increased neuropeptide Y mRNA expression in striatum in Parkinson's disease","volume":"110","author":"Cannizzaro","year":"2003","journal-title":"Brain Research Molecular Brain Research"},{"key":"10.1016\/j.bbr.2013.01.039_bib0085","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ana.410230202","article-title":"Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease","volume":"23","author":"Kowall","year":"1988","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.bbr.2013.01.039_bib0090","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000117347","article-title":"Cerebrospinal fluid neuropeptide Y in Alzheimer's disease","volume":"30","author":"Alom","year":"1990","journal-title":"European Neurology"},{"key":"10.1016\/j.bbr.2013.01.039_bib0095","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0304-3940(95)11973-Z","article-title":"Plasma neuropeptide Y is reduced in patients with Alzheimer's disease","volume":"198","author":"Koide","year":"1995","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.bbr.2013.01.039_bib0100","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000106636","article-title":"Somatostatin and neuropeptide Y in cerebrospinal fluid: correlations with severity of disease and clinical signs in Alzheimer's disease and frontotemporal dementia","volume":"8","author":"Minthon","year":"1997","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1016\/j.bbr.2013.01.039_bib0105","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0196-9781(01)00571-X","article-title":"Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia","volume":"22","author":"Nilsson","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.bbr.2013.01.039_bib0110","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.neurobiolaging.2011.06.018","article-title":"Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease","volume":"9","author":"Decressac","year":"2012","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.bbr.2013.01.039_bib0115","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1523\/JNEUROSCI.4220-08.2009","article-title":"Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease","volume":"29","author":"Rose","year":"2009","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.039_bib0120","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000323468","article-title":"Neuroprotective effect of neuropeptide Y against beta-amyloid 25-35 toxicity in SH-SY5Y neuroblastoma cells is associated with increased neurotrophin production","volume":"8","author":"Croce","year":"2011","journal-title":"Neurodegenerative Diseases"},{"key":"10.1016\/j.bbr.2013.01.039_bib0125","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1021\/cn200127e","article-title":"Neuropeptide Y protects rat cortical neurons against beta-amyloid toxicity and re-establishes synthesis and release of nerve growth factor","volume":"3","author":"Croce","year":"2012","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.039_bib0130","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer's disease","volume":"6","author":"Selkoe","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2013.01.039_bib0135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.1016\/j.bbr.2013.01.039_bib0140","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.npep.2012.09.001","article-title":"Multifaces of neuropeptide Y in the brain \u2013 neuroprotection, neurogenesis and neuroinflammation","volume":"46","author":"Malva","year":"2012","journal-title":"Neuropeptides"},{"key":"10.1016\/j.bbr.2013.01.039_bib0145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbr.2006.11.032","article-title":"Differential susceptibility following beta-amyloid peptide-(1\u201340) administration in C57BL\/6 and Swiss albino mice: evidence for a dissociation between cognitive deficits and the glutathione system response","volume":"177","author":"Prediger","year":"2007","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2013.01.039_bib0150","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuroscience.2007.11.009","article-title":"Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease","volume":"151","author":"Prediger","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.039_bib0155","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1523\/JNEUROSCI.5047-06.2007","article-title":"Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein","volume":"27","author":"Medeiros","year":"2007","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.039_bib0160","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/nrd2075","article-title":"Drug discovery in dementia: the role of rodent models","volume":"5","author":"Van Dam","year":"2006","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.bbr.2013.01.039_bib0165","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brainres.2009.05.035","article-title":"Validation of Abeta1\u201340 administration into mouse cerebroventricles as an animal model for Alzheimer disease","volume":"1280","author":"Takeda","year":"2009","journal-title":"Brain Research"},{"key":"10.1016\/j.bbr.2013.01.039_bib0170","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.2353\/ajpath.2009.081113","article-title":"Role of the macrophage inflammatory protein-1{alpha}\/CC chemokine receptor 5 signaling pathway in the neuroinflammatory response and cognitive deficits induced by {beta}-amyloid peptide","volume":"175","author":"Passos","year":"2009","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.bbr.2013.01.039_bib0175","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/JAD-2010-101320","article-title":"Folic acid plus \u03b1-tocopherol mitigates amyloid-\u03b2-induced neurotoxicity through modulation of mitochondrial complexes activity","volume":"24","author":"Figueiredo","year":"2011","journal-title":"Journal of Alzheimers Disease"},{"key":"10.1016\/j.bbr.2013.01.039_bib0180","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.expneurol.2011.11.036","article-title":"Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid \u03b2 peptide in mice","volume":"233","author":"Santos","year":"2012","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.bbr.2013.01.039_bib0185","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0891-5849(96)00629-6","article-title":"Oxidative stress hypothesis in Alzheimer's disease","volume":"23","author":"Markesbery","year":"1997","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.bbr.2013.01.039_bib0190","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.nbd.2009.02.017","article-title":"Neuropeptide Y stimulates proliferation, migration and differentiation of neural precursors from the subventricular zone in adult mice","volume":"34","author":"Decressac","year":"2009","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.bbr.2013.01.039_bib0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1476-5381.1957.tb01354.x","article-title":"Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse","volume":"12","author":"Haley","year":"1957","journal-title":"British Journal of Pharmacology and Chemotherapy"},{"key":"10.1016\/j.bbr.2013.01.039_bib0200","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(95)01032-7","article-title":"Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction","volume":"706","author":"Maurice","year":"1996","journal-title":"Brain Research"},{"key":"10.1016\/j.bbr.2013.01.039_bib0205","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1016\/j.peptides.2006.07.020","article-title":"Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze","volume":"27","author":"Bacchi","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.bbr.2013.01.039_bib0210","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbr.2010.03.052","article-title":"Altered emotionality leads to increased pain tolerance in amyloid beta (Abeta1\u201340) peptide-treated mice","volume":"212","author":"Pamplona","year":"2010","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2013.01.039_bib0215","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.039_bib0220","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF00177912","article-title":"The use of a plus-maze to measure anxiety in the mouse","volume":"92","author":"Lister","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.039_bib0225","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0091-3057(94)90472-3","article-title":"Ethopharmacological analysis of rat behavior on the elevated plus-maze","volume":"49","author":"Cruz","year":"1994","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/j.bbr.2013.01.039_bib0230","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.physbeh.2006.09.013","article-title":"Characteristics of object location memory in mice: behavioral and pharmacological studies","volume":"90","author":"Murai","year":"2007","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.bbr.2013.01.039_bib0235","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbr.2009.06.005","article-title":"Object location memory in mice: pharmacological validation and further evidence of hippocampal CA1 participation","volume":"204","author":"Assini","year":"2009","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2013.01.039_bib0240","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3233\/JAD-2012-120541","article-title":"Age-related cognitive decline in hypercholesterolemic LDL receptor knockout mice (LDLr\u2212\/\u2212): evidence of antioxidant imbalance and increased acetylcholinesterase activity in the prefrontal cortex","volume":"32","author":"Moreira","year":"2012","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.bbr.2013.01.039_bib0245","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/j.bbr.2013.01.039_bib0250","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/j.bbr.2013.01.039_bib0255","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0076-6879(85)13062-4","article-title":"Glutathione reductase","volume":"113","author":"Carlberg","year":"1985","journal-title":"Methods in Enzymology"},{"key":"10.1016\/j.bbr.2013.01.039_bib0260","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0076-6879(81)77046-0","article-title":"Glutathione peroxidase","volume":"77","author":"Wendel","year":"1981","journal-title":"Methods in Enzymology"},{"key":"10.1016\/j.bbr.2013.01.039_bib0265","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein\u2013dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/j.bbr.2013.01.039_bib0270","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1515\/BC.2003.059","article-title":"Glutathione pathways in the brain","volume":"384","author":"Dringen","year":"2003","journal-title":"Biological Chemistry"},{"key":"10.1016\/j.bbr.2013.01.039_bib0275","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0006-8993(90)90082-M","article-title":"Neuropeptide Y receptor binding sites in human brain. Possible alteration in Alzheimer's disease","volume":"519","author":"Martel","year":"1990","journal-title":"Brain Research"},{"key":"10.1016\/j.bbr.2013.01.039_bib0280","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nature02621","article-title":"Pathways towards and away from Alzheimer's disease","volume":"430","author":"Mattson","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2013.01.039_bib0285","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0006-8993(89)91706-X","article-title":"Modulation of memory processing by neuropeptide Y varies with brain injection site","volume":"503","author":"Flood","year":"1989","journal-title":"Brain Research"},{"key":"10.1016\/j.bbr.2013.01.039_bib0290","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1096\/fj.02-0885fje","article-title":"Activation of neuropeptide Y receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures","volume":"17","author":"Silva","year":"2003","journal-title":"FASEB Journal"},{"key":"10.1016\/j.bbr.2013.01.039_bib0295","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2174\/1568007054546153","article-title":"The putative neuroprotective role of neuropeptide Y in the central nervous system","volume":"4","author":"Silva","year":"2005","journal-title":"Current Drug Targets CNS and Neurological Disorders"},{"key":"10.1016\/j.bbr.2013.01.039_bib0300","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.npep.2009.02.002","article-title":"Neuroprotective effects of neuropeptide Y-Y2 and Y5 receptor agonists in vitro and in vivo","volume":"43","author":"Smia\u0142owska","year":"2009","journal-title":"Neuropeptides"},{"key":"10.1016\/j.bbr.2013.01.039_bib0305","article-title":"Neurodegeneration, beta-amyloid and mood disorders: state of the art and future perspectives","author":"Piccinni","year":"2012","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1016\/j.bbr.2013.01.039_bib0310","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2013.01.039_bib0315","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/archpsyc.65.5.542","article-title":"Amyloid-associated depression: a prodromal depression of Alzheimer disease","volume":"65","author":"Sun","year":"2008","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.bbr.2013.01.039_bib0320","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0166-4328(02)00033-5","article-title":"Enhanced antidepressant effect of sigma(1) (sigma(1)) receptor agonists in beta(25\u201335)-amyloid peptide-treated mice","volume":"134","author":"Urani","year":"2002","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2013.01.039_bib0325","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1016\/S0014-2999(99)00800-6","article-title":"Neuropeptide Y exerts antidepressant-like effects in the forced swim test in rats","volume":"387","author":"Stogner","year":"2000","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.bbr.2013.01.039_bib0330","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0893-133X(01)00403-1","article-title":"The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test","volume":"26","author":"Redrobe","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2013.01.039_bib0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/brbi.1996.0001","article-title":"The effects of central administration of neuropeptide Y on behavior, neurotransmitter, and immune functions in the olfactory bulbectomized rat model of depression","volume":"10","author":"Song","year":"1996","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.bbr.2013.01.039_bib0340","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-3806(01)00264-4","article-title":"Early maternal separation alters neuropeptide Y concentrations in selected brain regions in adult rats","volume":"131","author":"Jimenez-Vasquez","year":"2001","journal-title":"Brain Research Developmental Brain Research"},{"key":"10.1016\/j.bbr.2013.01.039_bib0345","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0169-328X(98)00137-5","article-title":"Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region specific adaptation after fluoxetine treatment","volume":"59","author":"Caberlotto","year":"1998","journal-title":"Brain Research Molecular Brain Research"},{"key":"10.1016\/j.bbr.2013.01.039_bib0350","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1471-4914(01)02173-6","article-title":"Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide","volume":"7","author":"Butterfield","year":"2001","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.bbr.2013.01.039_bib0355","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1046\/j.1471-4159.1997.68052061.x","article-title":"An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease","volume":"68","author":"Lyras","year":"1997","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.bbr.2013.01.039_bib0360","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(94)90131-7","article-title":"Hydrogen peroxide mediates amyloid beta protein toxicity","volume":"77","author":"Behl","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2013.01.039_bib0365","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.bbadis.2006.03.002","article-title":"Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer's disease","volume":"1762","author":"Ono","year":"2006","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.bbr.2013.01.039_bib0370","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1212\/WNL.45.8.1594","article-title":"Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease","volume":"45","author":"Lovell","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2013.01.039_bib0375","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1471-4159.2005.03109.x","article-title":"Role of glutathione in intracellular amyloid-alpha precursor protein\/carboxy-terminal fragment aggregation and associated cytotoxicity","volume":"93","author":"Woltjer","year":"2005","journal-title":"Journal of Neurochemistry"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813000661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813000661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:02:36Z","timestamp":1759064556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432813000661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":75,"alternative-id":["S0166432813000661"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2013.01.039","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-\u03b2 (A\u03b21\u201340) administration in mice","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2013.01.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}